BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10611988)

  • 1. Four distinct neurologic syndromes in Marek's disease: effect of viral strain and pathotype.
    Gimeno IM; Witter RL; Reed WM
    Avian Dis; 1999; 43(4):721-37. PubMed ID: 10611988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An acute form of transient paralysis induced by highly virulent strains of Marek's disease virus.
    Witter RL; Gimeno IM; Reed WM; Bacon LD
    Avian Dis; 1999; 43(4):704-20. PubMed ID: 10611987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
    Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very virulent plus strains of MDV induce an acute form of transient paralysis in both susceptible and resistant chicken lines.
    Xu M; Fitzgerald SD; Zhang H; Karcher DM; Heidari M
    Viral Immunol; 2012 Aug; 25(4):306-23. PubMed ID: 22803780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coinfection of specific-pathogen-free chickens with Marek's disease virus (MDV) and chicken infectious anemia virus: effect of MDV pathotype.
    Miles AM; Reddy SM; Morgan RW
    Avian Dis; 2001; 45(1):9-18. PubMed ID: 11332504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system.
    Abdul-Careem MF; Hunter BD; Sarson AJ; Mayameei A; Zhou H; Sharif S
    Viral Immunol; 2006; 19(2):167-76. PubMed ID: 16817759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Marek's disease virus pathotype and replication.
    Dunn JR; Auten K; Heidari M; Buscaglia C
    Avian Dis; 2014 Jun; 58(2):287-92. PubMed ID: 25055634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathotyping: a new system to classify Marek's disease virus.
    Gimeno IM; Witter RL; Neumann U
    Avian Dis; 2002; 46(4):909-18. PubMed ID: 12495052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Marek's disease field isolates by the "best fit" pathotyping assay.
    Dudnikova E; Norkina S; Vlasov A; Slobodchuk A; Lee LF; Witter RL
    Avian Pathol; 2007 Apr; 36(2):135-43. PubMed ID: 17479374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased virulence of Marek's disease virus field isolates.
    Witter RL
    Avian Dis; 1997; 41(1):149-63. PubMed ID: 9087332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine expression in the eye and brain of chickens following infection with a very virulent plus Marek's disease virus strain.
    Salvador C; Cortes AL; Pandiri AR; Gimeno IM
    Vet Immunol Immunopathol; 2021 Jul; 237():110277. PubMed ID: 34090158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and Identification of Marek's Disease Virus BAC Clones as Standardized Reagents for Research.
    Dunn JR; Reddy SM; Niikura M; Nair V; Fulton JE; Cheng HH
    Avian Dis; 2017 Mar; 61(1):107-114. PubMed ID: 28301231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains.
    Yunis R; Jarosinski KW; Schat KA
    Virology; 2004 Oct; 328(1):142-50. PubMed ID: 15380365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two serotype 1 MDV isolates.
    Miles AM; Anderson AS; Bernberg EL; Kent J; Rosenberger JK; Pope CR; Morgan RW
    Acta Virol; 1999; 43(2-3):102-5. PubMed ID: 10696428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathotyping of recent Indian field isolates of Marek's disease virus serotype 1.
    Suresh P; Johnson Rajeswar J; Sukumar K; Harikrishnan TJ; Srinivasan P
    Acta Virol; 2015 Jun; 59(2):156-65. PubMed ID: 26104332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marek's disease virus infection in the brain: virus replication, cellular infiltration, and major histocompatibility complex antigen expression.
    Gimeno IM; Witter RL; Hunt HD; Lee LF; Reddy SM; Neumann U
    Vet Pathol; 2001 Sep; 38(5):491-503. PubMed ID: 11572556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.